
Dynamic leader in GMP compliance and quality operations with over 18 years of experience, specializing in the development and scaling of global supplier governance for clinical and commercial programs. Proven track record in centralizing vendor oversight, optimizing global CMO quality operations, and significantly reducing audit cycle times while remediating Quality Agreement backlogs. Solid focus on lot disposition, batch release oversight, and deviation/CAPA management. Adept at implementing risk-based quality systems aligned with FDA and EU GMP standards (Annex 16), complemented by executive-level quality metrics reporting to ensure continuous improvement and regulatory compliance.
• Lead global vendor qualification and lifecycle governance across clinical through commercial operations, overseeing 60+ CMOs, contract laboratories, and GxP service providers to ensure GMP compliance and sustained inspection readiness.
• Establish risk-based supplier classification, re-qualification, and lifecycle oversight strategies aligned with ICH Q9 Quality Risk Management, FDA, and EU GMP standards.
• Oversee end-to-end supplier lifecycle activities within Veeva QMS, including qualification, performance monitoring, and retirement/discontinuation management.
• Lead negotiation and governance of global Quality Agreements, reducing turnaround time from ~300 days to ~100 days through standardized templates and cross-functional collaboration.
• Develop supplier performance metrics and compliance dashboards, leading Quality Management Reviews (QMRs) to identify compliance risks and drive proactive mitigation.
• Implement risk-based supplier audit strategies, reducing audit cycle time from ~150 days to ~90–100 days while enhancing global supplier risk visibility.
• Coordinate vendor management inspection readiness activities, serving as Back Room Lead during FDA and global regulatory inspections and overseeing documentation control and audit support.
• Serve as Subject Matter Expert (SME) for supplier qualification and oversight, directly engaging with regulatory investigators during audits and inspections.
• Support global regulatory readiness for EU commercialization, collaborating with Qualified Persons (QP) and aligning vendor oversight practices with EU GMP and Annex 16 requirements.
Oversaw GMP batch record review and lot disposition, ensuring documentation accuracy, completeness, and compliance with FDA and EU GMP requirements.